BIIB
Price
$125.84
Change
-$0.46 (-0.36%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
31.34B
60 days until earnings call
BYND
Price
$2.84
Change
-$0.09 (-3.07%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
535.53M
80 days until earnings call
Interact to see
Advertisement

BIIB vs BYND

Header iconBIIB vs BYND Comparison
Open Charts BIIB vs BYNDBanner chart's image
Biogen
Price$125.84
Change-$0.46 (-0.36%)
Volume$19.56K
Capitalization31.34B
Beyond Meat
Price$2.84
Change-$0.09 (-3.07%)
Volume$22.96K
Capitalization535.53M
BIIB vs BYND Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BYND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIIB vs. BYND commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and BYND is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (BIIB: $126.30 vs. BYND: $2.93)
Brand notoriety: BIIB and BYND are both notable
BIIB represents the Pharmaceuticals: Major, while BYND is part of the Food: Specialty/Candy industry
Current volume relative to the 65-day Moving Average: BIIB: 54% vs. BYND: 96%
Market capitalization -- BIIB: $31.34B vs. BYND: $535.53M
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. BYND’s [@Food: Specialty/Candy] market capitalization is $535.53M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Food: Specialty/Candy] industry ranges from $327.81B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Food: Specialty/Candy] industry is $9.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 0 FA rating(s) are green whileBYND’s FA Score has 0 green FA rating(s).

  • BIIB’s FA Score: 0 green, 5 red.
  • BYND’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIIB and BYND are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 4 TA indicator(s) are bullish while BYND’s TA Score has 4 bullish TA indicator(s).

  • BIIB’s TA Score: 4 bullish, 4 bearish.
  • BYND’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than BYND.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +2.10% price change this week, while BYND (@Food: Specialty/Candy) price change was +18.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.69%. For the same industry, the average monthly price growth was +2.39%, and the average quarterly price growth was -0.07%.

The average weekly price growth across all stocks in the @Food: Specialty/Candy industry was -0.01%. For the same industry, the average monthly price growth was +0.07%, and the average quarterly price growth was -4.12%.

Reported Earning Dates

BIIB is expected to report earnings on Jul 23, 2025.

BYND is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.69% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Food: Specialty/Candy (-0.01% weekly)

A specialty/candy manufacturer specializes in one or more of the following: chocolate, candies, pasta, condiments, seasonings, among other items. Hershey Company, McCormick & Company and J.M. Smucker Company are some of the major firms in this segment. Demand for this industry’s products comes from both institutions/restaurants as well as households.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($31.3B) has a higher market cap than BYND($536M). BIIB YTD gains are higher at: -17.408 vs. BYND (-22.074). BIIB has higher annual earnings (EBITDA): 2.04B vs. BYND (-282.19M). BIIB has more cash in the bank: 1.05B vs. BYND (191M). BYND has less debt than BIIB: BYND (1.22B) vs BIIB (7.34B). BIIB has higher revenues than BYND: BIIB (9.84B) vs BYND (343M).
BIIBBYNDBIIB / BYND
Capitalization31.3B536M5,840%
EBITDA2.04B-282.19M-722%
Gain YTD-17.408-22.07479%
P/E Ratio26.95N/A-
Revenue9.84B343M2,868%
Total Cash1.05B191M550%
Total Debt7.34B1.22B603%
FUNDAMENTALS RATINGS
BIIB vs BYND: Fundamental Ratings
BIIB
BYND
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
71100
PRICE GROWTH RATING
1..100
6164
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
7595

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIIB's Valuation (87) in the Biotechnology industry is in the same range as BYND (89) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

BIIB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BYND (100) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

BIIB's SMR Rating (71) in the Biotechnology industry is in the same range as BYND (100) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

BIIB's Price Growth Rating (61) in the Biotechnology industry is in the same range as BYND (64) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

BIIB's P/E Growth Rating (96) in the Biotechnology industry is in the same range as BYND (100) in the Food Meat Or Fish Or Dairy industry. This means that BIIB’s stock grew similarly to BYND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIIBBYND
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
53%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BYND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPO120.63N/A
N/A
XPO
TCBI72.35N/A
N/A
Texas Capital Bancshares
NFGC1.22N/A
N/A
New Found Gold Corp
CYBN7.02N/A
N/A
Cybin Inc
SBFM1.40-0.02
-1.41%
Sunshine Biopharma Inc

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.41%
AMGN - BIIB
52%
Loosely correlated
+0.21%
NVS - BIIB
48%
Loosely correlated
-0.25%
PFE - BIIB
48%
Loosely correlated
N/A
SNY - BIIB
42%
Loosely correlated
N/A
MRK - BIIB
40%
Loosely correlated
N/A
More